Several drugs raise oxytocin levels, ranging from synthetic oxytocin given in hospitals to MDMA, certain antidepressants, and even specific probiotics. The most direct way is synthetic oxytocin itself, but other substances trigger your brain to release more of its own supply through different pathways.
Synthetic Oxytocin (Pitocin)
The most straightforward drug that increases oxytocin is, well, oxytocin itself. Pitocin is a synthetic version delivered by IV drip or injection in hospital settings. It’s used almost exclusively in obstetric care: inducing labor, strengthening contractions, and controlling bleeding after delivery. This isn’t something you’d take at home. It requires careful medical monitoring because the dosing window is narrow, and too much can cause dangerous drops in blood pressure, abnormal heart rhythms, or a condition called water intoxication where the body retains so much fluid that electrolyte levels crash.
Intranasal Oxytocin Spray
Researchers have been studying oxytocin delivered as a nasal spray, primarily for autism spectrum disorder. The idea is that a puff of oxytocin absorbed through the nasal lining can reach the brain and improve social responsiveness. Trials have tested a range of doses in both adults and children, with treatment periods lasting four to twelve weeks. Some results are promising: adults with autism showed improved emotion recognition and quality of life after six weeks of twice-daily use, and children aged three to six showed gains in parent-reported social responsiveness after five weeks.
The results aren’t uniformly positive, though. In some trials, only higher doses produced measurable improvements, and effects varied widely between individuals. Intranasal oxytocin is not approved as a standard treatment for any psychiatric condition, though it continues to be actively studied.
MDMA
MDMA is one of the most potent triggers of oxytocin release studied so far. At a dose of 1.5 mg/kg, it raised plasma oxytocin from a baseline of about 18.6 pg/ml to a peak of 83.7 pg/ml, roughly a four-and-a-half-fold increase. Levels climbed within 60 minutes and peaked around two hours after ingestion. Every participant in the study showed some increase, though the magnitude varied widely, with individual responses ranging from a 20 to 150 pg/ml jump above baseline.
The mechanism involves serotonin. MDMA floods the brain with serotonin, which then stimulates specific serotonin receptors that trigger oxytocin-producing neurons to fire. This oxytocin surge is thought to be a key driver behind MDMA’s characteristic feelings of emotional closeness and empathy, though researchers note that the subjective effects likely involve other neurotransmitter systems too, not just oxytocin alone. A lower dose (0.75 mg/kg) did not significantly raise oxytocin levels, suggesting a threshold effect.
SSRIs and Antidepressants
Because MDMA works partly through serotonin, it’s natural to ask whether everyday serotonin-boosting antidepressants do the same thing. The answer is complicated. In animal studies, both acute and chronic administration of SSRIs like citalopram increased plasma oxytocin secretion. But human studies tell a less clear story. One clinical trial measuring oxytocin in people with major depression found no significant difference in oxytocin levels before versus after SSRI treatment.
The disconnect likely comes down to dose intensity. SSRIs gradually raise serotonin availability over weeks, while MDMA causes a massive, sudden flood. The gentle nudge from an antidepressant may not cross the threshold needed to meaningfully boost oxytocin in most people, or the effect may be too subtle to detect in blood samples.
Estrogen
Estrogen doesn’t just raise oxytocin levels directly. It also increases the number of oxytocin receptors in key brain areas, making the brain more sensitive to whatever oxytocin is already circulating. Animal research shows that estrogen restores oxytocin levels in the brain, upregulates oxytocin receptor protein expression, and amplifies the signaling effects of oxytocin at the cellular level. When estrogen receptors were blocked in these studies, the enhanced oxytocin signaling disappeared.
This helps explain why oxytocin’s effects tend to be more pronounced in women during phases of the menstrual cycle when estrogen is high, during pregnancy, and after childbirth. It also means that anything affecting estrogen levels, from hormonal contraceptives to menopause, could indirectly shift how strongly your oxytocin system responds.
Melanocortin Receptor Agonists
Drugs that activate melanocortin receptors in the brain, originally developed for sexual dysfunction, appear to stimulate oxytocin-producing neurons as a secondary effect. The connection runs through a brain region called the paraventricular nucleus, which sends oxytocin-releasing projections down the spinal cord. When melanocortin receptors are activated there, oxytocin neurons show increased activity. When those receptors are blocked, both the neural activity and the associated behaviors drop off. This class of drug isn’t primarily designed to boost oxytocin, but the interaction between the melanocortin and oxytocin systems in the brain is well documented in animal research.
Probiotics
One of the more surprising entries on this list is a specific gut bacterium. Supplementation with Lactobacillus reuteri, a probiotic strain, has been shown to increase oxytocin levels in both animal and human studies. In one trial, women taking a probiotic blend containing L. reuteri experienced a greater increase in oxytocin levels compared to those on placebo, alongside improvements in eating behavior and greater reductions in BMI. The gut-brain pathway involved isn’t fully mapped, but the finding has been replicated enough times to be taken seriously.
What Doesn’t Work: GHB
GHB is sometimes assumed to raise oxytocin because of its reputation for producing feelings of sociability and emotional warmth. A controlled study in 16 healthy males tested this directly and found that GHB had no effect on oxytocin levels. It did increase progesterone and improve mood, but the prosocial feelings it produces appear to work through entirely different brain chemistry. If you’ve seen GHB listed as an oxytocin booster online, the evidence doesn’t support it.
Risks of Artificially Raising Oxytocin
Oxytocin isn’t purely a “feel-good” molecule, and pushing levels higher carries real risks depending on the method. Synthetic IV oxytocin can cause cardiac arrhythmias, dangerous spikes or drops in blood pressure, seizures, and water intoxication that in severe cases leads to coma. It also interacts badly with certain anesthetics and drugs that affect heart rhythm, prolonging the QT interval and raising the risk of cardiac events.
Even intranasal oxytocin, which is far gentler, has shown inconsistent results across trials. Oxytocin doesn’t just promote bonding and trust. It can also intensify negative social emotions like envy and suspicion of outsiders, depending on context. The popular image of oxytocin as a simple “love hormone” is misleading. Its effects depend heavily on the social situation, your baseline brain chemistry, and how much is being delivered.